{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:26:05Z","timestamp":1791278765309,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2005.12.052","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:06:46Z","timestamp":1137697606000},"page":"10-11","source":"Crossref","is-referenced-by-count":8,"title":["Yellow fever vaccination: Some thoughts on how much is enough [Vaccine 23 (2005) 3908\u20133914]"],"prefix":"10.1016","volume":"25","author":[{"given":"Reinaldo M.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Silva","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Antonio B.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Lourdes S.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.12.052_bib1","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2005.03.002","article-title":"Yellow fever vaccination: how much is enough?","volume":"23","author":"Massad","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.12.052_bib2","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.12.052_bib3","series-title":"Vaccines","first-page":"1097","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.vaccine.2005.12.052_bib4","unstructured":"WHO. International travel and health, chapter 6\u2014vaccine preventable diseases, vaccines and vaccination, 2005 (http:\/\/www.who.int\/ith)."},{"issue":"2","key":"10.1016\/j.vaccine.2005.12.052_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre amarela [Yellow fever]","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"issue":"12","key":"10.1016\/j.vaccine.2005.12.052_bib6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trstmh.2003.12.019","article-title":"Risk assessment of yellow fever urbanization in Rio de Janeiro, Brazil","volume":"98","author":"Code\u00e7o","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2005.12.052_bib7","unstructured":"WHO. Progress in the control of yellow fever in Africa. Wkly Epidemiol Rec 2005;80(6):49\u201360, p. 52."},{"key":"10.1016\/j.vaccine.2005.12.052_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-1157(81)80036-4","article-title":"A clinical study of stabilized 17D strain live attenuated yellow fever vaccine","volume":"9","author":"Moss-Blundell","year":"1981","journal-title":"J Biol Stand"},{"issue":"3","key":"10.1016\/j.vaccine.2005.12.052_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0034-89102005000300012","article-title":"Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial","volume":"39","author":"Camacho","year":"2005","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vaccine.2005.12.052_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.12.052_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.12.052_bib12","unstructured":"Centers for Disease Control and Prevention. Health Information for International Travel 2005\u20132006. US Department of Health and Human Services, Public Health Service, Atlanta."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:53:56Z","timestamp":1547870036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06000144"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.12.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}